Prescription Drug News and Research

RSS

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Medicare Advantage plans marked by shortcomings

The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts.

14 Oct 2014

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3 isavuconazole VITAL study being presented at IDWeek on October 10, 2014, in Philadelphia, Pa.

8 Oct 2014

Connecture launches private health insurance exchange solution, On Ramp

Connecture, Inc. ("Connecture"), a leading provider of web-based information systems used to create health insurance marketplaces, today announced the immediate availability of On Ramp, a full service, private health insurance exchange solution and corresponding benefits portal that provides the functionality needed to dramatically enhance the delivery of employee benefits and empower consumers to make more informed health insurance decisions with ease.

7 Oct 2014

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting (PONV). The data generated demonstrated a statistically significant reduction in the incidence of PONV with APD421 compared to placebo in adult surgical patients at moderate to high risk of suffering PONV (PONV is defined as any episode of emesis or use of antiemetic rescue medication in the first 24 hours after surgery).

7 Oct 2014

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.

6 Oct 2014

State highlights: Fla. toughens drug compounding laws; Conn. hospitals leave largest insurer

A selection of health policy stories from Florida, Connecticut, New York, Michigan, Louisiana, Pennsylvania and Arkansas.

1 Oct 2014

Agingcare.com introduces Prescription Drug Assistance Locator tool

Paying for prescription medications just got easier for families who frequent AgingCare.com, the go-to destination for family caregivers.

1 Oct 2014

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.

30 Sep 2014

CVS to pay $6M to settle Medicaid reimbursement case

Caremark LLC, a unit of CVS, will make the payments to settle allegations that it knowingly failed to reimburse Medicaid for prescription drug costs paid on behalf of patients who were also covered by private plans it administered. The company denied wrongdoing.

29 Sep 2014

CVS/pharmacy renews Medication Disposal for Safer Communities donation program

CVS/pharmacy announced today that is marking National Prescription Drug Take Back Day on Saturday, September 27 by renewing its innovative community donation program to support local drug collection efforts by law enforcement.

25 Sep 2014

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories, Inc., a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug products from AstraZeneca, 17 of which were marketed.

25 Sep 2014

Capital Bluecross encourages people to make use of National Prescription Drug Take-Back Day

To support a nationwide effort to clear homes of potentially dangerous, expired, unused and unwanted prescription drugs, Capital BlueCross is reminding residents to take advantage of the Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Day from 10 a.m. to 2 p.m. Saturday, Sept. 27. Take-Back Day collection is free and anonymous.

24 Sep 2014

Teens around the world frequently use OTC and prescription medications without doctor's order

Adolescents around the world are frequently using over-the-counter and prescription medications without a doctor's order, a risky practice that can lead to overuse and abuse and is often continued into adulthood, reveals a new review in the Journal of Adolescent Health.

24 Sep 2014

Viewpoints: Ezekiel Emanuel's choice of an age to die; new enrollment numbers still confusing

Seventy-five. That's how long I want to live: 75 years. This preference drives my daughters crazy. It drives my brothers crazy. My loving friends think I am crazy. They think that I can't mean what I say; that I haven't thought clearly about this, because there is so much in the world to see and do. To convince me of my errors, they enumerate the myriad people I know who are over 75 and doing quite well. They are certain that as I get closer to 75, I will push the desired age back to 80, then 85, maybe even 90. I am sure of my position.

22 Sep 2014

New expert panel report on state of therapeutic products for children

A new expert panel report, Improving Medicines for Children in Canada, released today by the Council of Canadian Academies, addresses the importance of developing safe and effective medicines for children.

19 Sep 2014

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Prescription drug abuse is an extremely complex problem with no single solution. For example, the very same medications that are so critical for alleviating pain in legitimate patients could easily be diverted and misused by other people.

16 Sep 2014

Complete analysis of the global stem cell market

BCC Research reveals in its new report, THE GLOBAL MARKET FOR STEM CELLS, the global market for stem cells is expected to grow to nearly $10.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 13.6%.

16 Sep 2014

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen (NASDAQ: AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) in Las Vegas.

15 Sep 2014

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

15 Sep 2014

Prescription Drug News and Research

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Medicare Advantage plans marked by shortcomings

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Connecture launches private health insurance exchange solution, On Ramp

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

State highlights: Fla. toughens drug compounding laws; Conn. hospitals leave largest insurer

Agingcare.com introduces Prescription Drug Assistance Locator tool

AAN releases new position statement on opioids for chronic non-cancer pain

CVS to pay $6M to settle Medicaid reimbursement case

CVS/pharmacy renews Medication Disposal for Safer Communities donation program

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

Capital Bluecross encourages people to make use of National Prescription Drug Take-Back Day

Teens around the world frequently use OTC and prescription medications without doctor's order

Viewpoints: Ezekiel Emanuel's choice of an age to die; new enrollment numbers still confusing

New expert panel report on state of therapeutic products for children

Combating prescription drug abuse: an interview with Mark Trudeau and Carmen Catizone

Complete analysis of the global stem cell market

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News